Antibiotics

Produced by the strain of Streptomyces griseus MJ361-48F3, it showed activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 0.39-1.56 μg/mL.

Produced by the strain of Micromonospora olivoasterospora, it has a weak antibacterial activity.

Fosfadecin is produced by the strain of Pseudomonas fluorescens PK-5. It has a weak antibacterial activity, the ED50 of Escherichia coli O-111 and Staphylococcus aureus 308A-1 was 800mg/kg and 566mg/kg (mice, oral).

Fosfazinomycin A is produced by the strain of Streptomyces lavendofoliae. It has the activity of resisting plant pathogenic fungi such as Xanthomonas oryzae.

Fosfazinomycin B is produced by the strain of Streptomyces lavendofoliae. It has the activity of resisting plant pathogenic fungi such as Xanthomonas oryzae.

It is produced by the strain of Pseudomonas fluorescens PK-52. It has very weak antibacterial activity.

It is produced by the strain of Talaromyces flavus SANK 15680 and Fusarium oxysporum SANK 10182. Chloroacetylphosphoric acid only has the activity of anti-proteus bacteria, but in the presence of glucose-6-phosphate (G-6-P), it is also effective against Staphylococcus aureus, Escherichia coli, Haemophilus haemophilus, some Shigella and Salmonella bacteria. The mechanism of antibacterial action is to inhibit cell wall biosynthesis and affect the formation of plasmoglobin.

Fragilomycin A is produced by the strain of Streptosporangium fragilis SK & F-BC2496. It has anti-gram-negative bacteria and anaerobic bacteria activity.

Produced by the strain of Streptomyces griseus (FCRC-48), Fredericamycin A has anti-gram-positive bacterial and fungal activity, and shows strong anti-tumor effect in vivo and in vitro.

Frenolicin is produced by the strain of Streptomyces fradiae. It has anti-gram-positive bacterial and fungal (weak) activity.

One of the antibiotics produced by the strain of Streptomyces roseofulvus AM-3876. It has antifungal and mycoplasma activities.

An antibiotic originally isolated from Actinoplanes friuliensis sp. HAG 010964. Friulimicin A has the activity of inhibiting the synthesis of peptidoglycan. It is a naturally occurring cyclic lipopeptide, with excellent activity against gram-positive pathogens through cell wall interruption, including multidrug-resistant strains.

An antibiotic originally isolated from Actinoplanes friuliensis sp. HAG 010964. Friulimicin B has the activity of inhibiting the synthesis of peptidoglycan. It is a naturally occurring cyclic lipopeptide, with excellent activity against gram-positive pathogens through cell wall interruption, including multidrug-resistant strains.

It is produced by the strain of Streptomyces sp. Fujianmycin A has anti-subtilis activity.

It is produced by the strain of Streptomyces sp. Fujianmycin B requires a high concentration to show its activity.

Fulvoferruginin is produced by the strain of Marasmius fuloferrugineus. It showed cytotoxicity and antifungal activity, especially to Paecilomyces varioti with MIC of 1-5 μg/mL.

Fulvoplumierin is produced by the strain of Plumeria acutifolia.

It is produced by the strain of Penicillum resticulosum. It has anti-gram-positive bacterial activity.

Fumarylcarboxyamido-L-2,3-diaminopropionyl-L-alanine is produced by the strain of Streptomyces collinus A-19006. It has antifungal and trichomonas effects.

Fumifungin is produced by the strain of Aspergollus fumigatus Fresenius 1863. It has the antifungal activities of Cercospora, Cladosporium, Aspergillus niger, Penicillium digitatum, Trichophyton mentagrophytes, Alternaria, Candida albicans and yeast.